WCN25-1128 IgA DOMINANT INFECTION RELATED GLOMERULONEPHRITIS

WCN25-1128 IgA DOMINANT INFECTION RELATED GLOMERULONEPHRITIS

Saved in:

Bibliographic Details
Main Authors:	Fatima Alkindi, Dr. Fatima AlKindi, Suhail Al-Salam, Mohamed H. Hassan, Ahmad Chaaban, Mohammad Al Hakim, Nihal Bashir, George Abraham, Mohamed Saad, Imran Khan, Mohammed Budruddin, Asma Al Neyadi, Yousef Boobes
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023957
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-116 IT'S RARE BUT THERE: SEVER ANGIOEDEMA FOLLOWING RITUXIMAB TREATMENT FOR SEVER LUPUS NEPHRITIS
by: nihal bashir, et al.
Published: (2025-02-01)

Aberrantly Glycosylated IgA1 as a Factor in the Pathogenesis of IgA Nephropathy
by: Mototsugu Tanaka, et al.
Published: (2011-01-01)

IgA Nephropathy in the Elderly
by: Dana V. Rizk, et al.
Published: (2025-08-01)

Serum IgA/C3 ratio as a diagnostic and prognostic biomarker for IgA nephropathy
by: Anitha Swamy, et al.
Published: (2025-08-01)

Corrigendum to “Is childhood IgA nephropathy different from adult IgA nephropathy? A narrative review”
Published: (2025-07-01)

WCN24-802 ALPORT SYNDROME WITH PODOCYTOPATHY
by: NIHAL BASHIR, et al.
Published: (2024-04-01)

Clinical and diagnostic significance of isolated detection of IgA antibodies to deamidated gliadin peptides in IgA nephropathy patients
by: M. E. Mantsaeva, et al.
Published: (2025-05-01)

Dynamics of chromatin accessibility governing Gd-IgA1 synthesis in B cells associated with IgA nephropathy
by: Yangang Gan, et al.
Published: (2025-07-01)

IgA肾病的治疗进展
by: 刘双信, et al.
Published: (2015-01-01)

LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy
by: Koshi Yamada, et al.
Published: (2024-02-01)

Evaluation the Efficacy of ELISA IgG, IgM and IgA Tests for Diagnosis of Helicobacter pylori
by: Hogir Mohammed Shukri Saadi, et al.
Published: (2018-09-01)

A comparative study of Islamic conformity, profitability, and green performance in Southeast Asian Islamic banks
by: Muhammad Alkindi, et al.
Published: (2025-03-01)

Effect and Safety of Finerenone in Patients with IgA Nephropathy
by: Guo Y, et al.
Published: (2025-07-01)

Understanding the natural history of selective IgA deficiency
by: Nayara Maria Furquim Nasser, et al.
Published: (2025-07-01)

Specific IgA antibodies in the diagnosis of acute brucellosis
by: Hanan El-Mohammady, et al.
Published: (2011-09-01)

WCN25-4456 GLOMERULOCYSTIC KIDNEY DISEASE: KEY INSIGHTS AND LESSONS LEARNED
by: Suhail Al-Salam, et al.
Published: (2025-02-01)

Relationship between renal deposition of complement C3， IgG， IgM and pathology in IgA nephropathy
by: Fang-cao Lu, et al.
Published: (2022-08-01)

Detection of IgM, IgG and IgA against pertussis in pregnant women in I - II - III trimesters
by: T. A. Skirda, et al.
Published: (2021-10-01)

WCN25-3843 IT IS NOT ALWAYS DIABETIC NEPHROPATHY: A CASE REPORT OF FIBRILLARY GLOMERULONEPHRITIS
by: Reima Almarshoodi, et al.
Published: (2025-02-01)

Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in IgA Vasculitis
by: Kaoru Ikeno, et al.
Published: (2024-03-01)

Granulomatosis with Polyangiitis Misdiagnosed as IgA Vasculitis in a Child
by: Sheida Amini, et al.
Published: (2023-01-01)

Personal thoughts of IgA nephropathy and purpura nephritis in children
by: Zhang Hong-wen
Published: (2022-07-01)

RETRACTED: Nephroprotective effect of losartan in IgA model rat
by: Li Xing, et al.
Published: (2019-10-01)

The health-related quality of life in children with IgA vasculitis
by: Juan Zhou, et al.
Published: (2025-05-01)

Clinical observation on Shenning mixture in treating IgA nephropathy
by: LIU Hong-yan, et al.
Published: (2016-01-01)

The value of biomarkers in the diagnosis and prognostic analysis of IgA nephropathy
by: Lu Min, et al.
Published: (2025-01-01)

Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy
by: Zinaida Sh. Kochoyan, et al.
Published: (2024-01-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-4090 The Diagnostic potential of Serum Gd-IgA1 to C3 ratio in IgA nephropathy: A single center prospective study
by: Ravi tej Madipalli, et al.
Published: (2025-02-01)

Current status of clinical studies of IgA nephropathy with minimal proteinuria
by: SHI Yu-zhen, et al.
Published: (2020-01-01)

Clinicopathologic and prognostic analyses in elderly patients with primary IgA nephropathy
by: LIU Lin-lin, et al.
Published: (2017-01-01)

Meta-analysis of tacrolimus combined with hormone therapy for IgA nephropathy
by: LIU Hui-bin, et al.
Published: (2017-01-01)

IgA肾病发病机制研究纵览
by: 李慧琼, et al.
Published: (2016-01-01)

Hepatitis B Virus Status and Clinical Outcomes in IgA Nephropathy
by: Mei-zhu Gao, et al.
Published: (2024-04-01)

Selective IgA deficiency and congenital adrenal hyperplasia. Is there a relationship?
by: V. V. Kuznecova, et al.
Published: (2023-04-01)

Clinical, laboratory, radiological features, and outcome of acute fat embolism syndrome in sickle cell disease
by: Alkindi Salam, et al.
Published: (2025-07-01)

WCN24-2188 THE CLINICOPATHOLOGICAL SPECTRUM OF IGA DOMINANT/CODOMINANT GLOMERULONEPHRITIS DIAGNOSED AT AN ACADEMIC CENTRE IN SRI LANKA
by: Dilushi Wijayaratne, et al.
Published: (2024-04-01)

Total and partial IgA deficiency in blood serum in children. Clinical observation
by: T. B. Pavlova, et al.
Published: (2017-05-01)

IgA肾病发病机制的相关研究进展
by: 王菲菲, et al.
Published: (2024-01-01)